News
6 Oct 2020
KOLINPHARMA® obtains its 5th patent in the USA for MILESAX® !
MILESAX® was granted because of the recognized innovation and uniqueness of the composition, with muscle relaxant and anti-inflammatory activity.
To date, Kolinpharma has obtained 4 industrial patents in Italy, 3 patents in 12 new European countries beyond Italy, 5 patents in the United States and 1 in Israel, a conquest that is a source of great pride in countries considered a worldwide reference in scientific research and of great importance in the world of nutraceuticals which testifies to the seriousness and accuracy research and confirms the ability of the R&D team to study innovative formulations and develop effective products, based on the most current scientific evidence in the various reference areas.
Mentioned Companies
Kolinpharma
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance